Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1997-01-30
2000-11-21
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 932, 514 44, 435325, A61K 4800, C12N 500, C12N 1500
Patent
active
061499048
ABSTRACT:
In its broadest terms, the invention provides methods for the enhanced intracellular delivery of therapeutically active molecules to a target tumor cell. In a preferred embodiment, the method comprises providing engineered cells that express a heterologous nucleic acid that encodes a connexin and that contain a pro-drug activating gene, and contacting target tumor cells in a solid tumor with engineered cells that form functional gap junctions with said target tumor cells, such that the therapeutic molecule passes through a gap junction to a target tumor cell. More particularly, the invention involves providing engineered non-tumorigenic cells that express a first heterologous nucleic acid that encodes a connexin and a second heterologous nucleic acid that encodes a pro-drug activating molecule that converts a nontoxic substrate to a toxic metabolite, then contacting tumor cells in a solid tumor with engineered cells that form functional gap junctions with said tumor cells, and then exposing the engineered and tumor cells to the nontoxic substrate, whereby the nontoxic substrate is converted to the toxic metabolite in cells that expresses the pro-drug activating molecule, and the toxic metabolite then passes through gap junctions to adjacent coupled tumor cells, thereby inhibiting the cell growth of the tumor cells that contain the toxic metabolite.
REFERENCES:
Marini III, F.C. et al., Gene Therapy 2:655 (1995).
Fick, James. et al., Proc. Natl. Acad. Sci. USA 92:11071 (1995).
Bechberger, J.F. et al. Abstract Molecular Biology/Biochemistry Proceedings of the American Association for Cancer Research 36:520 (1995).
Bruzzone et al. Eur. J. Biochem. 238(1):1-27 (1996).
Chen, T.-H. et al. Cell Biology and Toxicology 1:155 (1984).
Davis, L.M. et al. Journal of Cardiovascular Electrophysiology 6:103 (1995).
Edelman, G.M., Biochem, 27:3533-3543 (1988).
Eghbali et al., Proc. Natl. Acad. Sci. USA, 87:1328-1331 (1990).
Elfgang et al. J. Cell Biol. 129(3):805-817 (1995).
Fick, J. et al. West J Med 161:260 (1994).
Fick, J. et al. Crit Rev Neurosurg 4:1 (1994).
Fick, J. et al. Abstract 2515 Proceedings of the American Association for Cancer Research 36:422 (1995).
Fick, J. et al. Crit Rev Neurosurg 5:85 (1995).
Fishman et al., Cell Adhesion and Communication 3:353-65 (1995).
Hofer, A. et al. J. Neuroscience 16(14)4311-21 (1996).
Holder, J.W. et al., Cancer Research, 53:3475-3485 (1993).
Jongen, W.M.F. et al., J. Cell Biol., 114:545-555 (1991).
Keane, R.W. et al., J. Cell Biol., 106:1307-1319 (1988).
Koval, M. et al., J. Cell Biol. 130:987-95 (1995).
Lee, S.W. et al. The Journal of Cell Biology 118:1213 (1992).
Mesnil et al. Proc. Natl. Acad. Sci. USA, 93:1831-1835. (1996).
Meyer, R.A. et al., J. Cell Biol., 119:179-189 (1992).
Moore, L.K. et al., Amer. J. Physiol. 267(5 Pt 1):C1371-C1380 (1994).
Musil, L.S. et al., J. Cell Biol., 111:2077-2088 (1990).
Naus, C.C.G. et al. Cellular and Molecular Neurobiology 12:163 (1992).
Naus, C.C.G. et al. Cancer Research 52:4208 (1992).
Naus, C.C.G. et al. Experimental Cell Research 206:72 (1993).
Pitts, J.D. Molecular Carcinogenesis 11:127 (1994).
Ruch, R.J. Annals of Clinical and Laboratory Science 24:216 (1994).
Shinoura, N. et al., J. Neurosurg. 84(5):839-846 (1996).
Vitkauskas, G.V. et al. Biochima et Biophysica Acta 823:19 (1985).
Zhu, D. et al., Proc. Natl. Acad. Sci. USA, 89:10218-10221 (1992).
Zhu,D. et al., Proc. Natl. Acad. Sci. USA, 88:1883-1887 (1991).
Bi, W.L. et al., In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy, Human Gene Therapy, 4:725-731, (1993).
Fick et al. (1995) Proced. Natl. Acad. 92, 11071-11075.
Blau et al (1995) The New England J. Med, Nov. 2, 1204-1207.
Barba et al (1994) Proced. Natl. Acad Sci. 91, 4348-4352.
Fick James R.
Israel Mark A.
Crouch Deborah
The Regents of the University of California
LandOfFree
Method for inhibiting tumor cell growth by administering to tumo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting tumor cell growth by administering to tumo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting tumor cell growth by administering to tumo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1254257